Accelrys has acquired privately held VelQuest, a developer of software systems for use in federally regulated lab environments, for $35 million.

The all-cash acquisition will allow Accelrys to extend its product portfolio beyond research and development into late-stage product development and quality control, where compliance with the US Food and Drug Administration's Good Manufacturing Practices is required, the company said.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.